Forint Surges on MNB Rate Pause Speculation
Forex Rebecca Torres

Forint Surges on MNB Rate Pause Speculation

Hungary's forint strengthened 1.1% against the euro after reports suggested the central bank may halt rate cuts, widening the carry cushion.

VGK
Turkish Diesel at 90 Lira, Tax Hikes Could Push It Past 100
Economy Daniel Marsh

Turkish Diesel at 90 Lira, Tax Hikes Could Push It Past 100

Turkish diesel prices have exceeded 90 lira per liter, and a scheduled tax increase could push them past 100 by January, adding to inflation pressures as the central bank considers rate cuts.

SPY
Boeing's F-15EX Milestone: $131B Ceiling vs. Tiny Funded Amount
Analysis Daniel Marsh

Boeing's F-15EX Milestone: $131B Ceiling vs. Tiny Funded Amount

Boeing moves first F-15EX to Kadena, but the $131B contract ceiling is not backlog; only $343,740 is funded. Stock closes at $212.25, up 0.81%.

BA
Volkswagen Surges 6.5% on Overhaul Approval, But Profit Gap Looms
Markets Daniel Marsh

Volkswagen Surges 6.5% on Overhaul Approval, But Profit Gap Looms

Volkswagen shares jumped 6.5% after its supervisory board unanimously backed a historic restructuring plan. The market cheered, but a €19.2 billion profit gap remains.

Angels' $4B Deal Puts Braves' Valuation in Perspective
Analysis Daniel Marsh

Angels' $4B Deal Puts Braves' Valuation in Perspective

A reported $4 billion price for the Angels aligns closely with Atlanta Braves Holdings' enterprise value, but the comparison is less bullish once debt and non-baseball assets are considered.

BATRA BATRK
SpaceX Faces 378M Share Lockup Expiry; Trading Risk Ahead
IPO Michael Okonkwo

SpaceX Faces 378M Share Lockup Expiry; Trading Risk Ahead

SpaceX (SPCX) faces a 378.1M share lockup expiry this week, equal to 7.7 days of trading. Q2 revenue surged 92%, but losses persist. Analysts see 103% upside.

Teva Secures Full Investment-Grade Status; Refinancing Gains Ahead
Markets Daniel Marsh

Teva Secures Full Investment-Grade Status; Refinancing Gains Ahead

Teva Pharmaceutical Industries (NYSE:TEVA) now holds investment-grade ratings from all three major agencies. The milestone, achieved without a stock rally, sets the stage for better refinancing terms.

Cemig's Sá Carvalho Renewal: A Small Step in a Big Concession Puzzle
Analysis Daniel Marsh

Cemig's Sá Carvalho Renewal: A Small Step in a Big Concession Puzzle

Cemig's Sá Carvalho renewal covers just 4.4% of its concession exposure, leaving the fate of two larger plants unresolved.

U.S. Hits Iranian Tankers, WTI Rally Faces Key Test
Commodities Rebecca Torres

U.S. Hits Iranian Tankers, WTI Rally Faces Key Test

U.S. forces struck three Iranian tankers Saturday, injecting fresh geopolitical risk into oil markets after WTI's 9.7% weekly surge. Futures open Sunday; stocks resume Tuesday.

XLE XOM CVX AAL UAL USO
Intel's $21B Surge Sparks Trillion-Dollar Valuation Debate
Analysis Daniel Marsh

Intel's $21B Surge Sparks Trillion-Dollar Valuation Debate

Intel's stock surged 4.5% on Friday, adding $21B in market cap. Analysts disagree wildly on its value, from $92 to $200 per share, putting a trillion-dollar market cap in question.

INTC DELL
Fubo's Disney-Linked Valuation: What Investors Need to Know
Analysis Daniel Marsh

Fubo's Disney-Linked Valuation: What Investors Need to Know

FuboTV (FUBO) shares gained 9% last week, but the real story is Disney's 70% economic stake, which changes the valuation math. Fully converted equity is worth $1.23 billion.

FUBO DIS
AbbVie Completes $10.9B Apogee Buyout, Earnings Lift Delayed to 2032
Analysis Daniel Marsh

AbbVie Completes $10.9B Apogee Buyout, Earnings Lift Delayed to 2032

AbbVie finalizes its $10.9B Apogee Therapeutics deal, with earnings accretion not expected until 2032. The acquisition tests investor patience as immunology sales fuel the wait.

ABBV APGE